Earlier, several studies have revealed that a favorable prognosis is associated with CRTC1/3-MAML2 gene rearrangements in younger people, and with a tumor of low to intermediate grade [38,47,48,49,50]. This evidence concerns the gene CRTC1 and neoplasm.